231 related articles for article (PubMed ID: 17433788)
21. Early events in human colorectal carcinogenesis. Aberrant crypts and microadenoma.
Roncucci L
Ital J Gastroenterol; 1992; 24(9):498-501. PubMed ID: 1489980
[TBL] [Abstract][Full Text] [Related]
22. [Genetics and molecular classification of colorectal cancer].
Søreide K
Tidsskr Nor Laegeforen; 2007 Nov; 127(21):2818-23. PubMed ID: 17987073
[TBL] [Abstract][Full Text] [Related]
23. The identification of monoclonality in human aberrant crypt foci.
Siu IM; Robinson DR; Schwartz S; Kung HJ; Pretlow TG; Petersen RB; Pretlow TP
Cancer Res; 1999 Jan; 59(1):63-6. PubMed ID: 9892186
[TBL] [Abstract][Full Text] [Related]
24. Reliability and accuracy of the endoscopic appearance in the identification of aberrant crypt foci.
Gupta AK; Pinsky P; Rall C; Mutch M; Dry S; Seligson D; Schoen RE
Gastrointest Endosc; 2009 Aug; 70(2):322-30. PubMed ID: 19539919
[TBL] [Abstract][Full Text] [Related]
25. Aberrant crypt foci of the colon as precursors of adenoma and cancer.
Takayama T; Katsuki S; Takahashi Y; Ohi M; Nojiri S; Sakamaki S; Kato J; Kogawa K; Miyake H; Niitsu Y
N Engl J Med; 1998 Oct; 339(18):1277-84. PubMed ID: 9791143
[TBL] [Abstract][Full Text] [Related]
26. Chemoprevention of colorectal cancer.
Niitsu Y; Takayama T; Miyanishi K; Nobuoka A; Hayashi T; Kukitsu T; Takanashi K; Ishiwatari H; Abe T; Kogawa T; Takahashi M; Matsunaga T; Kato J
Cancer Chemother Pharmacol; 2004 Sep; 54 Suppl 1():S40-3. PubMed ID: 15309513
[TBL] [Abstract][Full Text] [Related]
27. Aberrant crypt foci in patients with a positive family history of sporadic colorectal cancer.
Stevens RG; Swede H; Heinen CD; Jablonski M; Grupka M; Ross B; Parente M; Tirnauer JS; Giardina C; Rajan TV; Rosenberg DW; Levine J
Cancer Lett; 2007 Apr; 248(2):262-8. PubMed ID: 16950561
[TBL] [Abstract][Full Text] [Related]
28. Histomorphology of aberrant crypt foci in colorectal carcinoma.
Norlida AO; Phang KS
Malays J Pathol; 2010 Dec; 32(2):111-6. PubMed ID: 21329182
[TBL] [Abstract][Full Text] [Related]
29. Instability of X chromosome methylation in aberrant crypt foci of the human colon.
Sakurazawa N; Tanaka N; Onda M; Esumi H
Cancer Res; 2000 Jun; 60(12):3165-9. PubMed ID: 10866306
[TBL] [Abstract][Full Text] [Related]
30. Endoscopic identification and quantification of aberrant crypt foci in the human colon.
Adler DG; Gostout CJ; Sorbi D; Burgart LJ; Wang L; Harmsen WS
Gastrointest Endosc; 2002 Nov; 56(5):657-62. PubMed ID: 12397272
[TBL] [Abstract][Full Text] [Related]
31. The adenoma hunt in colorectal cancer screening: defining the target.
Sillars-Hardebol AH; Carvalho B; van Engeland M; Fijneman RJ; Meijer GA
J Pathol; 2012 Jan; 226(1):1-6. PubMed ID: 21984228
[TBL] [Abstract][Full Text] [Related]
32. The colorectal adenoma-carcinoma sequence.
Leslie A; Carey FA; Pratt NR; Steele RJ
Br J Surg; 2002 Jul; 89(7):845-60. PubMed ID: 12081733
[TBL] [Abstract][Full Text] [Related]
33. Myeloperoxidase-positive cell infiltration in colorectal carcinogenesis as indicator of colorectal cancer risk.
Roncucci L; Mora E; Mariani F; Bursi S; Pezzi A; Rossi G; Pedroni M; Luppi D; Santoro L; Monni S; Manenti A; Bertani A; Merighi A; Benatti P; Di Gregorio C; de Leon PM
Cancer Epidemiol Biomarkers Prev; 2008 Sep; 17(9):2291-7. PubMed ID: 18768495
[TBL] [Abstract][Full Text] [Related]
34. [Effects of tea on aberrant crypt foci and colorectal tumors in rats].
Jia X; Wang W; Cui W; Han C
Wei Sheng Yan Jiu; 2000 Jan; 29(1):54-6. PubMed ID: 12725046
[TBL] [Abstract][Full Text] [Related]
35. Natural history of human aberrant crypt foci and correlation with risk factors for colorectal cancer.
Ohkubo H; Takahashi H; Yamada E; Sakai E; Higurashi T; Uchiyama T; Hosono K; Endo H; Taguri M; Nakajima A
Oncol Rep; 2012 May; 27(5):1475-80. PubMed ID: 22246586
[TBL] [Abstract][Full Text] [Related]
36. Aberrant crypt foci: detection, gene abnormalities, and clinical usefulness.
Takayama T; Miyanishi K; Hayashi T; Kukitsu T; Takanashi K; Ishiwatari H; Kogawa T; Abe T; Niitsu Y
Clin Gastroenterol Hepatol; 2005 Jul; 3(7 Suppl 1):S42-5. PubMed ID: 16012995
[TBL] [Abstract][Full Text] [Related]
37. Comment re: "Sporadic aberrant crypt foci are not a surrogate endpoint for colorectal adenoma prevention" and "Aberrant crypt foci in the adenoma prevention with celecoxib trial".
Stevens RG; Pretlow TP; Hurlstone DP; Giardina C; Rosenberg DW
Cancer Prev Res (Phila); 2008 Aug; 1(3):215-6; author reply 216. PubMed ID: 19138959
[No Abstract] [Full Text] [Related]
38. Aberrant crypt foci and beta-catenin accumulated crypts; significance and roles for colorectal carcinogenesis.
Mori H; Yamada Y; Kuno T; Hirose Y
Mutat Res; 2004 May; 566(3):191-208. PubMed ID: 15082237
[TBL] [Abstract][Full Text] [Related]
39. APC and K-ras gene mutation in aberrant crypt foci of human colon.
Yuan P; Sun MH; Zhang JS; Zhu XZ; Shi DR
World J Gastroenterol; 2001 Jun; 7(3):352-6. PubMed ID: 11819789
[TBL] [Abstract][Full Text] [Related]
40. Aberrant crypt foci as microscopic precursors of colorectal cancer.
Cheng L; Lai MD
World J Gastroenterol; 2003 Dec; 9(12):2642-9. PubMed ID: 14669304
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
